Form 4 · Filed May 27, 2026, 09:50 PM UTC
KYMR/Kymera Therapeutics, Inc.
Chadwick Jeremy G — Chief Operating Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
7 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 27, 2026 | S | sell | 3,679 | $82 | $299,850 | 44,618 |
| May 27, 2026 | S | sell | 600 | $82 | $49,246 | 44,018 |
| May 26, 2026 | S | sell | 3,800 | $79 | $301,691 | 53,348 |
| May 26, 2026 | S | sell | 3,730 | $78 | $292,271 | 57,472 |
| May 26, 2026 | S | sell | 551 | $81 | $44,470 | 48,297 |
| May 26, 2026 | S | sell | 4,500 | $80 | $360,111 | 48,848 |
| May 26, 2026 | S | sell | 324 | $79 | $25,651 | 57,148 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-242266